S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
S&P 500   3,370.29 (-0.29%)
DOW   29,232.19 (-0.56%)
QQQ   234.73 (+0.04%)
AAPL   319.00 (-1.83%)
FB   217.80 (+1.69%)
MSFT   187.23 (+1.01%)
GOOGL   1,519.44 (+0.05%)
AMZN   2,155.67 (+0.97%)
CGC   21.94 (-0.86%)
NVDA   296.57 (+2.34%)
BABA   220.52 (+0.41%)
MU   57.75 (-1.28%)
GE   12.75 (-0.62%)
TSLA   858.40 (+7.30%)
AMD   56.89 (+2.86%)
T   38.26 (+0.03%)
ACB   1.64 (+3.80%)
F   8.06 (-0.49%)
NFLX   387.78 (+1.94%)
PRI   135.62 (-0.89%)
BAC   34.27 (-1.66%)
DIS   139.14 (-0.29%)
GILD   67.01 (-0.81%)
Log in

CNSX:PLUS - PLUS Products Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
$1.09
MA: $1.45▼
$1.68
52-Week Range N/A
Volume19,879 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Plus Products Inc. manufactures cannabis products in California. It offers cannabis-infused edibles to the regulated medicinal and adult-use, or recreational markets. The company also provides gummies in Nevada market. It sells products under the PLUS brand to dispensaries and delivery service customers. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

Industry, Sector and Symbol

Stock Exchange CNSX
Industry Pharmaceuticals: Other
Sub-IndustryN/A
SectorMedical
Current SymbolCNSX:PLUS
Previous Symbol
CUSIPN/A
CIKN/A
Webhttp://www.plusproductsinc.com/
Phone+1 213.282.6987

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableOptionable

Receive PLUS News and Ratings via Email

Sign-up to receive the latest news and ratings for PLUS and its competitors with MarketBeat's FREE daily newsletter.

TSXV:PLUS Rates by TradingView

PLUS Products (CNSX:PLUS) Frequently Asked Questions

What is PLUS Products' stock symbol?

PLUS Products trades on the CNSX under the ticker symbol "PLUS."

What price target have analysts set for PLUS?

1 brokers have issued 1 year price targets for PLUS Products' stock. Their forecasts range from $7.99 to $7.99. On average, they anticipate PLUS Products' stock price to reach $7.99 in the next year. View Analyst Price Targets for PLUS Products.

What is the consensus analysts' recommendation for PLUS Products?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PLUS Products in the last year. There are currently 1 strong buy rating for the stock, resulting in a consensus recommendation of "Strong Buy." View Analyst Ratings for PLUS Products.

Has PLUS Products been receiving favorable news coverage?

News coverage about PLUS stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. PLUS Products earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for PLUS Products.

Who are some of PLUS Products' key competitors?

What other stocks do shareholders of PLUS Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PLUS Products investors own include Sierra Oncology (SRRA), Co-Diagnostics (CODX), Actinium Pharmaceuticals (ATNM), Curaleaf (CURLF), Allena Pharmaceuticals (ALNA), Digital Ally (DGLY), Inpixon (INPX), Kopin (KOPN), Onconova Therapeutics (ONTX) and Tonix Pharmaceuticals (TNXP).

Who are PLUS Products' key executives?

PLUS Products' management team includes the folowing people:
  • Mr. Craig F. Heimark, Chairman, Chief Strategy Officer & Sec. (Age 64)
  • Mr. Jacob F. Heimark, Co-Founder, CEO & Director
  • Ms. Jennifer Tung, Chief Risk Officer
  • Mr. Justin Gwin, Co-Founder & Head of R&D
  • Ms. Lucie Herold, Co-Founder & Head of Sales

How do I buy shares of PLUS Products?

Shares of PLUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is PLUS Products' official website?

The official website for PLUS Products is http://www.plusproductsinc.com/.

How can I contact PLUS Products?

The company can be reached via phone at +1 213.282.6987 or via email at [email protected]


MarketBeat Community Rating for PLUS Products (CNSX PLUS)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  22 (Vote Outperform)
Underperform Votes:  16 (Vote Underperform)
Total Votes:  38
MarketBeat's community ratings are surveys of what our community members think about PLUS Products and other stocks. Vote "Outperform" if you believe PLUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PLUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: Float
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel